Invesco S&P International Developed Low Volatility ETF (IDLV)

Eddies gone but people will keep talking about him. You know the truth

Guessing we get no $ from Beats parts. Beats sells millions of units per year. If we got even a dollar per part, that would mean millions in revenue - even if we got under a dollar per part. I’m guessing Apple is not paying us anything. Wonder who is making the part for them.

Hold the line! The thing that I always go back to is that for the Government to make anything, the share price has to go up tremendously. In that case our share price will go up along with it. We are both needing a higher price per share to maximize this investment! GLTA!

Hi JoeForkeyBolo RE: AIM TQQQ

IMO AIM'ing TQQQ invites trouble sooner or later, weekly or monthly reviews is far too frequent that risks throwing your cash reserves into TQQQ at just the start of a deep dive. Six monthly reviews reduces that risk, but where AIM leveraging of downside

Assay labs do not cut (sample) your core for you.

Doesn’t matter if the greeners litigation is not against Dateline. What matters is there IS litigation to try and shutter the project…

I think you need not waste anymore time on nut jobs. You can't convince or argue with a person who calls a table a chair. They are way beyond the point of no return. These crackpots are growing in US and Europe, be it in investments or other circles.

Ah, meer details.

He isn't concerned about those failures because he had suckers, err, um, I mean investors that paid for the screw ups. Or taxpayers sometimes.

AI datacenters in space, pretty much impossible, doesn't matter, it sounds cool.🤣

lol can we get a little context here spec?

Secret UFO tape discovered after 70 years may reveal hidden details about 'Invasion of Washington'

~ The tape is set to be in the storage of a research center, which will reportedly make it available.

~ by www.thenews.com.pk/writer/the-news-digital The News Digital ,

INLF INLF INLF WOOOOOO

Futu Holdings Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FUTUJune 29, 2026 3:41 AM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"June 29, 2026 /PRNewswire

Banger. -  There is NO Market for hydrogen fuel cells for backup power.There are too many better / cheaper alternatives.
And for Primary Power the story is even worse.

I’m not bashing or sour on RITE, just a realist. All those losers that think I’m bashing and are their friends can bite me lol Don’t respond to my posts like I agree with you or were board buddies. 

It’s damn near July ( Mid Summer ) and I clearly remember saying it’s gonna be a looong summer. Got plenty of pushback…. Looks like a long fall is brewing now. Teens this week ? Very possible 

Sportradar Group AG Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SRADJune 29, 2026 3:23 AM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"June 29, 2026 /PRNewswire/

Thank you for the clarification.

GLTU

IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor AssessmentJune 29, 2026 3:00 AM
Business Wire IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment.

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental VitiligoJune 29, 2026 3:00 AM
PR Newswire (US) If approved, upadacitinib is expected to be the first systemi

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental VitiligoJune 29, 2026 3:00 AM
PR Newswire (US) If approved, upadacitinib is expected to be the first systemi

UK&I Clients Rank EPAM #1 for General Satisfaction in Whitelane Research ReportJune 29, 2026 3:02 AM
PR Newswire (US) Backed by strong client evaluations, EPAM's #1 rankings in general satisfaction, application services and service delive

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia AreataJune 29, 2026 3:10 AM
PR Newswire (US) Positive CHMP opinion is supported by data from the Phase 3 U